Jia Jie Biomedical Co Ltd (4109) — Cash Flow Reinvestment Rate
Jia Jie Biomedical Co Ltd (4109) has a Cash Flow Reinvestment Rate of 5.77x as of March 2026, reinvesting NT$74.69 Million (capex NT$5.84 Million plus investments NT$-68.84 Million) from operating cash flow of NT$12.96 Million. See 4109 free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Jia Jie Biomedical Co Ltd Cash Flow Reinvestment Rate (2015–2025)
Historical reinvestment intensity for Jia Jie Biomedical Co Ltd across 6 annual periods. For the full cash flow conversion analysis, see Jia Jie Biomedical Co Ltd cash flow conversion.
Annual Cash Flow Reinvestment Rate for Jia Jie Biomedical Co Ltd (2015–2025)
Year-by-year capital reinvestment analysis for Jia Jie Biomedical Co Ltd. See Jia Jie Biomedical Co Ltd financial flexibility index to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (TWD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 8.62x | NT$184.01 Million | NT$21.34 Million | NT$85.50 Million | ▲ +336.0% |
| 2024 | 1.98x | NT$87.70 Million | NT$44.35 Million | NT$19.63 Million | ▼ -94.8% |
| 2021 | 37.72x | NT$164.94 Million | NT$4.37 Million | NT$1.52 Million | ▲ +519.3% |
| 2020 | 6.09x | NT$165.05 Million | NT$27.10 Million | NT$1.63 Million | ▼ -15.8% |
| 2019 | 7.23x | NT$178.78 Million | NT$24.71 Million | NT$3.05 Million | ▲ +114.6% |
| 2015 | 3.37x | NT$277.22 Million | NT$82.22 Million | NT$273.85 Million | — |